AU2005254616A1 - Analysis of methylated nucleic acid - Google Patents

Analysis of methylated nucleic acid Download PDF

Info

Publication number
AU2005254616A1
AU2005254616A1 AU2005254616A AU2005254616A AU2005254616A1 AU 2005254616 A1 AU2005254616 A1 AU 2005254616A1 AU 2005254616 A AU2005254616 A AU 2005254616A AU 2005254616 A AU2005254616 A AU 2005254616A AU 2005254616 A1 AU2005254616 A1 AU 2005254616A1
Authority
AU
Australia
Prior art keywords
nucleic acid
methylated
sample
acid fragments
fragments
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AU2005254616A
Other languages
English (en)
Inventor
Dirk Schuebeler
Michael Philippe Weber
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Novartis Forschungsstiftung Zweigniederlassung Friedrich Miescher Institute for Biomedical Research
Original Assignee
Novartis Forschungsstiftung Zweigniederlassung Friedrich Miescher Institute for Biomedical Research
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Novartis Forschungsstiftung Zweigniederlassung Friedrich Miescher Institute for Biomedical Research filed Critical Novartis Forschungsstiftung Zweigniederlassung Friedrich Miescher Institute for Biomedical Research
Publication of AU2005254616A1 publication Critical patent/AU2005254616A1/en
Priority to AU2009202745A priority Critical patent/AU2009202745A1/en
Abandoned legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/10—Processes for the isolation, preparation or purification of DNA or RNA
    • C12N15/1003—Extracting or separating nucleic acids from biological samples, e.g. pure separation or isolation methods; Conditions, buffers or apparatuses therefor
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Biomedical Technology (AREA)
  • Organic Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Wood Science & Technology (AREA)
  • Zoology (AREA)
  • General Engineering & Computer Science (AREA)
  • Biotechnology (AREA)
  • General Health & Medical Sciences (AREA)
  • Molecular Biology (AREA)
  • Analytical Chemistry (AREA)
  • Biochemistry (AREA)
  • Crystallography & Structural Chemistry (AREA)
  • Physics & Mathematics (AREA)
  • Biophysics (AREA)
  • Plant Pathology (AREA)
  • Microbiology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Veterinary Medicine (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Peptides Or Proteins (AREA)
AU2005254616A 2004-06-18 2005-03-03 Analysis of methylated nucleic acid Abandoned AU2005254616A1 (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
AU2009202745A AU2009202745A1 (en) 2004-06-18 2009-07-07 Analysis of methylated nucleic acid

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
GBGB0413688.3A GB0413688D0 (en) 2004-06-18 2004-06-18 Analysis of methylated nucleic acid
GB0413688.3 2004-06-18
PCT/EP2005/002251 WO2005123942A2 (en) 2004-06-18 2005-03-03 Analysis of methylated nucleic acid

Related Child Applications (1)

Application Number Title Priority Date Filing Date
AU2009202745A Division AU2009202745A1 (en) 2004-06-18 2009-07-07 Analysis of methylated nucleic acid

Publications (1)

Publication Number Publication Date
AU2005254616A1 true AU2005254616A1 (en) 2005-12-29

Family

ID=32750180

Family Applications (2)

Application Number Title Priority Date Filing Date
AU2005254616A Abandoned AU2005254616A1 (en) 2004-06-18 2005-03-03 Analysis of methylated nucleic acid
AU2009202745A Ceased AU2009202745A1 (en) 2004-06-18 2009-07-07 Analysis of methylated nucleic acid

Family Applications After (1)

Application Number Title Priority Date Filing Date
AU2009202745A Ceased AU2009202745A1 (en) 2004-06-18 2009-07-07 Analysis of methylated nucleic acid

Country Status (8)

Country Link
US (2) US20090270482A1 (https=)
EP (1) EP1761639B1 (https=)
JP (1) JP2008502332A (https=)
AU (2) AU2005254616A1 (https=)
CA (1) CA2568575A1 (https=)
ES (1) ES2401110T3 (https=)
GB (1) GB0413688D0 (https=)
WO (1) WO2005123942A2 (https=)

Families Citing this family (19)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE102005034628B4 (de) * 2005-07-19 2007-08-23 Epigenomics Ag Verfahren zur Untersuchung von Cytosin-Methylierungen in DNA
EP1862555A1 (en) * 2006-05-29 2007-12-05 Klinikum der Universität Regensburg Means and methods for diagnosing cancer or a corresponding predisposition
WO2007149269A2 (en) * 2006-06-12 2007-12-27 Oncomethylome Sciences S.A. Methylation markers for early detection and prognosis of colon cancers
CN110079598A (zh) * 2007-10-23 2019-08-02 临床基因组学有限公司 诊断新生物的方法–ii
JP2009247260A (ja) * 2008-04-04 2009-10-29 Sumitomo Chemical Co Ltd Ｄｎａメチル化測定方法
WO2010118559A1 (zh) * 2009-04-17 2010-10-21 Lai Hung-Cheng 一种癌症筛检的方法
DK2529032T3 (en) * 2010-01-26 2017-05-01 Nipd Genetics Ltd METHODS AND COMPOSITIONS FOR NON-INVASIVE PRE-NATIONAL DIAGNOSTICATION OF Fetal ANEUPLOIDITIES
US8278049B2 (en) 2010-04-26 2012-10-02 Ann & Robert H. Lurie Children's Hospital of Chicago Selective enrichment of CpG islands
US20120004132A1 (en) * 2010-07-02 2012-01-05 Affymetrix, Inc. Detection of Nucleic Acids and Proteins
JP5916058B2 (ja) * 2011-08-26 2016-05-11 国立大学法人東北大学 細胞ストレス状態のバイオマーカー
US11021703B2 (en) 2012-02-16 2021-06-01 Cornell University Methods and kit for characterizing the modified base status of a transcriptome
WO2015025864A1 (ja) * 2013-08-21 2015-02-26 富士レビオ株式会社 吸収剤ポリヌクレオチドを用いた修飾核酸塩基の測定方法およびそのキット
PL3666902T3 (pl) 2015-05-22 2025-02-03 Medicover Public Co Ltd Multipleksowa równoległa analiza docelowych regionów genomowych do nieinwazyjnych badań prenatalnych
KR101735415B1 (ko) * 2015-07-31 2017-05-16 한국과학기술연구원 헥산알 노출 특이적 메틸화 마커 유전자 및 이를 이용한 확인 방법
JP6900325B2 (ja) * 2016-01-27 2021-07-07 住友化学株式会社 センサーチップ及びセンシングシステム
JP7441003B2 (ja) 2016-02-23 2024-02-29 ダブテイル ゲノミクス エルエルシー ゲノムアセンブリのためのフェージングされたリードセットの生成とハプロタイプフェージング
US12303561B2 (en) 2017-04-03 2025-05-20 Biontech Us Inc. Protein antigens and uses thereof
US11793867B2 (en) 2017-12-18 2023-10-24 Biontech Us Inc. Neoantigens and uses thereof
BR112020025764A2 (pt) 2018-06-19 2021-05-11 Biontech Us Inc. neoantígenos e usos dos mesmos

Family Cites Families (17)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5654183A (en) * 1992-07-27 1997-08-05 California Institute Of Technology Genetically engineered mammalian neural crest stem cells
US5518901A (en) * 1993-04-19 1996-05-21 Murtagh; James J. Methods for adapting nucleic acid for detection, sequencing, and cloning using exonuclease
US5714325A (en) * 1993-09-24 1998-02-03 New England Medical Center Hospitals Prenatal diagnosis by isolation of fetal granulocytes from maternal blood
US5866323A (en) * 1995-04-07 1999-02-02 Case Western Reserve University Cancer diagnosis prognosis and therapy based on mutation of receptors for transforming growth factor β and homologous growth controlling factors
US6251594B1 (en) * 1997-06-09 2001-06-26 Usc/Norris Comprehensive Cancer Ctr. Cancer diagnostic method based upon DNA methylation differences
US6337392B1 (en) * 1998-05-07 2002-01-08 The Rockefeller University Lens transcriptional control elements and methods of use thereof
US6994971B1 (en) * 1999-10-08 2006-02-07 University Of Utah Research Foundation Particle analysis assay for biomolecular quantification
CA2391530A1 (en) * 1999-11-19 2001-05-25 Thomas V. Tittle Tr3-specific binding agents and methods for their use
CA2412609C (en) * 2000-06-23 2010-09-07 The University Of Chicago Methods for isolating centromere dna
US20030157481A1 (en) * 2001-12-10 2003-08-21 Benjamin Thomas L. Diagnosing and treating cancer cells using T-HR mutants and their targets
AU2002318336A1 (en) * 2001-06-08 2002-12-23 U.S. Genomics, Inc. Methods and products for analyzing nucleic acids based on methylation status
WO2003070265A2 (en) * 2002-02-20 2003-08-28 Academisch Ziekenhuis Bij De Universiteit Van Amsterdam Hedgehog-related prophylaxis, therapy and diagnosis of gi tract carcinogenesis
ES2266374T3 (es) * 2002-09-18 2007-03-01 Sirs-Lab Gmbh Procedimiento para la deteccion de adn procariotico.
AU2003900368A0 (en) * 2003-01-24 2003-02-13 Human Genetic Signatures Pty Ltd Assay for nucleic acid molecules
JP3854943B2 (ja) * 2003-05-23 2006-12-06 独立行政法人科学技術振興機構 Ｄｎａメチル化率の測定方法
EP1524523A1 (en) * 2003-10-17 2005-04-20 Deutsches Krebsforschungszentrum Stiftung Des Öffentlichen Rechts Use of ADAM 12 for diagnosis and therapy of preeclampsia
DE602005023710D1 (de) * 2004-02-20 2010-11-04 Japan Science & Tech Agency Dna-array zur analyse der dna-methylierung, konstruktionsverfahren dafür sowie verfahren zur analyse der dna-methylierung

Also Published As

Publication number Publication date
AU2009202745A1 (en) 2009-07-30
GB0413688D0 (en) 2004-07-21
US20090270482A1 (en) 2009-10-29
EP1761639A2 (en) 2007-03-14
WO2005123942A2 (en) 2005-12-29
EP1761639B1 (en) 2013-01-02
WO2005123942A3 (en) 2006-04-13
CA2568575A1 (en) 2005-12-29
ES2401110T3 (es) 2013-04-17
US20120288509A1 (en) 2012-11-15
JP2008502332A (ja) 2008-01-31

Similar Documents

Publication Publication Date Title
US20120288509A1 (en) Analysis of methylated nucleic acid
CN107586835B (zh) 一种基于单链接头的下一代测序文库的构建方法及其应用
AU2017257225B2 (en) Allele editing and applications thereof
US10370725B2 (en) FGR fusions
US20190389969A1 (en) Ntrk2 fusions
EP3132054B1 (en) Met fusions
Patel et al. Tumor-specific retargeting of an oncogenic transcription factor chimera results in dysregulation of chromatin and transcription
US10246750B2 (en) Method for detection of a TECR:PKN1 or an ANXA4:PKN1 gene fusion
JP4527280B2 (ja) 示差スクリーニング
CN109837273B (zh) 一种crispr辅助dna靶向富集方法及其应用
AU2017200138A1 (en) Compositions and methods of nucleic acid-targeting nucleic acids
WO2001066719A1 (fr) Nouveau gene clone en neuroblastome humain et nouveaux fragments de gene
Keuthan et al. Alternative RNA splicing in the retina: insights and perspectives
Sankhe et al. Fusion oncogenes in rhabdomyosarcoma: model systems, mechanisms of tumorigenesis, and therapeutic implications
Sun et al. CRIPTO3, a presumed pseudogene, is expressed in cancer
AU2011203953B2 (en) Analysis of methylated nucleic acid
AU2003276609B2 (en) Qualitative differential screening for the detection of RNA splice sites
US20040076978A1 (en) Method to identify genes associated with chronic myelogenous leukemia
US20030059788A1 (en) Genetic markers of toxicity, preparation and uses thereof
Huang et al. CTCF mediates dosage and sequence-context-dependent transcriptional insulation through formation of local chromatin domains
US7932030B2 (en) System for pulling out regulatory elements using yeast
CN120350068B (zh) 一种可诱导靶向基因组dna双链断裂的质粒载体及细胞系
Schrier Regulation of Multiple Cellular Processes by the Long Noncoding RNA LINC00662
Liu Study of transcription-replication conflict and its role in genomic instability and cancer development
Ye Serial analysis of gene expression in human diseases

Legal Events

Date Code Title Description
MK5 Application lapsed section 142(2)(e) - patent request and compl. specification not accepted